Disease/Infection News

RSS

AIDS 2012 CCC selects Turning The Tide Together as theme for XIX international conference

The AIDS 2012 Conference Coordinating Committee (CCC) have selected Turning The Tide Together as the theme for the XIX International AIDS Conference (AIDS 2012), which will be held in Washington, D.C. from 22 - 27 July 2012.

21 Sep 2011

Matrix receives FDA's tentative approval for novel co-packaged version of HIV/AIDS therapy

Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited has received tentative approval from the U.S. Food and Drug Administration (FDA) through the President's Emergency Plan for AIDS Relief (PEPFAR) for its New Drug Application (NDA) for Lamivudine / Tenofovir Disoproxil Fumarate Tablets, 300 mg/300 mg, co-packaged with Nevirapine Tablets, 200 mg.

21 Sep 2011

Risk factors for variety of complications following spine surgery

In the last 20 years, due to diagnostic and surgical advances, more and more patients have become appropriate candidates for spine surgery, and the number of these procedures performed has risen significantly. While medical experts acknowledge the potential benefits of spine surgery, they also understand that complications can reduce the success in the short and long term.

21 Sep 2011

Viewpoints: Mixing politics and deficit cutting; transparency in health care; doctors' salaries

On the spending side, the president's plan takes a sensible approach toward saving money in Medicare and Medicaid. More than 90 percent of the $248 billion in Medicare cuts over 10 years would come from reducing payments to drug companies and health care providers that are unnecessarily high.

21 Sep 2011

MDC researchers determine molecular structure of dynamin

Dr. Katja F-lber and Professor Oliver Daumke, structural biologists at the Max Delbr-ck Center for Molecular Medicine (MDC) Berlin-Buch, together with researchers from Freie Universit-t (FU) Berlin, have determined the molecular structure of dynamin, a 'wire-puller' that mediates nutrient uptake into the cell.

21 Sep 2011

Report warns against shifting funding, prevention efforts away from countries successful in malaria fight

A new analysis conducted by the African Leaders Malaria Alliance, the Evidence to Policy Initiative at the University of California-San Francisco, and the Clinton Health Access Initiative "warns that if the countries that have produced impressive reductions in malaria cut or stop control activities, malaria will rapidly resurge and a decade of progress will have been in vain," BMJ News reports.

21 Sep 2011

NIH announces recipients of 2011 Transformative Research Award Projects

The National Institutes of Health has announced the recipients of the 2011 Transformative Research Award Projects. This innovative research program was established in 2009 to support exceptionally innovative, high risk, original and/or unconventional research projects, and is supported by the NIH Common Fund.

21 Sep 2011

Whooping cough vaccine may lose protective capacity in 3 years: Study

The whooping cough vaccine given to babies and toddlers loses much of its effectiveness after just three years. Doctors believe that could help explain a recent series of outbreaks in the U.S. among children who were fully vaccinated, a study suggests.

20 Sep 2011

Gilead’s new 4 in 1 combo HIV pill works

Gilead Sciences Inc's four-drug experimental HIV pill worked as well as a regimen containing protease inhibitor Reyataz in the second pivotal trial of the drug, the company announced this Monday. Although the trial succeeded, it did not show the experimental pill, called the Quad, was superior to the Reyataz regimen and Gilead shares fell less than a percentage point.

20 Sep 2011

Gilead’s Quad Phase 3 clinical study in treatment-naïve HIV-1 patients meets 48-week primary objective

Gilead Sciences, Inc. today announced that the second pivotal Phase 3 clinical trial of its investigational fixed-dose, single-tablet "Quad" regimen of elvitegravir, cobicistat, emtricitabine and tenofovir disoproxil fumarate, being evaluated for HIV-1 infection in treatment-naïve patients, met its primary objective of non-inferiority at week 48 as compared to ritonavir-boosted atazanavir plus Truvada.

20 Sep 2011

Liposomes block HIV infection in early tests

Could engineered fatty particles help prevent AIDS? Liposomes block HIV infection in early tests; could be a cost-effective preventive for developing countries

20 Sep 2011

Immune system uses zinc to destroy tuberculosis bacillus, E. coli

A new natural defense mechanism against infections has been evidenced by an international team led by researchers from CNRS, Inserm, the Institut Pasteur and the Université Paul Sabatier - Toulouse III.

20 Sep 2011

Scientists discover how liver destroys immune T-cells

Scientists at the Centenary Institute in Sydney have seen for the first time (in mice) how the liver goes independent, engulfing and destroying the body's defence troops-T-cells.

20 Sep 2011

Autopsy study reveals earliest 1918 pandemic influenza cases

Examination of lung tissue and other autopsy material from 68 American soldiers who died of respiratory infections in 1918 has revealed that the influenza virus that eventually killed 50 million people worldwide was circulating in the United States at least four months before the 1918 influenza reached pandemic levels that fall.

20 Sep 2011

New York Times examines possible entry into global market of generic drugs for NCDs

The New York Times describes how, as the U.N. begins its meeting on non-communicable diseases (NCDs), Chinese and Indian generic drug makers "say they are on the verge of selling cheaper copies" of costly biotech medications used to treat cancers, diabetes, arthritis and other chronic illnesses.

20 Sep 2011

Independent panel calls for stronger financial safeguards for Global Fund

After a six-month review of the financial systems at the Global Fund to Fight AIDS, Tuberculosis and Malaria, a seven-member independent panel "recommended a substantial overhaul Monday in the grant organization's practices," the Wall Street Journal reports.

20 Sep 2011

World Bank report examines gender equality, highlights mortality disparity between men and women

The World Bank's annual World Development Report, which was released on Sunday and this year "focuses on gender equality around the world, offers some stark facts about how women and girls fare in developing countries despite decades of progress," the Wall Street Journal reports (Reddy, 9/18). "The most glaring disparity is the rate at which girls and women die relative to men in developing countries, according to" the report, Reuters/AlertNet reports.

20 Sep 2011

'ScienceSpeaks' interviews director of technical leadership at OGAC

The Center for Global Health Policy's "ScienceSpeaks" blog features an interview with Caroline Ryan, director of technical leadership at the Office of U.S. Global AIDS Coordinator (OGAC), where she has worked for seven years. Ryan discusses PEPFAR program implementation, circumcision as an HIV prevention tool and balancing efficiency with the realization of new, but potentially costly, prevention tools.

20 Sep 2011

NCD draft declaration lacks specific targets, calls for nations to adopt recommendations for reducing chronic disease deaths

"World leaders at a meeting of the United Nations on Monday will agree to a deal to try to curb the spread of preventable 'lifestyle' diseases," including heart disease, cancers and diabetes, also known as non-communicable diseases (NCDs), "amid concern that progress is already being hampered by powerful lobbyists from the food, alcohol and tobacco industries," the Guardian reports.

20 Sep 2011

Major donors should consider funding for potential malaria vaccine

When the results of a large clinical trial testing the effectiveness of the RTS,S malaria vaccine among children in Africa are made available later this year, "it will be time to start discussing what to do with the vaccine," Orin Levine, executive director of the International Vaccine Access Center at Johns Hopkins University, writes in a Huffington Post opinion piece.

20 Sep 2011

Disease/Infection News

AIDS 2012 CCC selects Turning The Tide Together as theme for XIX international conference

Matrix receives FDA's tentative approval for novel co-packaged version of HIV/AIDS therapy

Risk factors for variety of complications following spine surgery

Viewpoints: Mixing politics and deficit cutting; transparency in health care; doctors' salaries

MDC researchers determine molecular structure of dynamin

Report warns against shifting funding, prevention efforts away from countries successful in malaria fight

NIH announces recipients of 2011 Transformative Research Award Projects

Whooping cough vaccine may lose protective capacity in 3 years: Study

Gilead’s new 4 in 1 combo HIV pill works

Gilead’s Quad Phase 3 clinical study in treatment-naïve HIV-1 patients meets 48-week primary objective

Liposomes block HIV infection in early tests

Immune system uses zinc to destroy tuberculosis bacillus, E. coli

Scientists discover how liver destroys immune T-cells

Autopsy study reveals earliest 1918 pandemic influenza cases

New York Times examines possible entry into global market of generic drugs for NCDs

Independent panel calls for stronger financial safeguards for Global Fund

World Bank report examines gender equality, highlights mortality disparity between men and women

'ScienceSpeaks' interviews director of technical leadership at OGAC

NCD draft declaration lacks specific targets, calls for nations to adopt recommendations for reducing chronic disease deaths

Major donors should consider funding for potential malaria vaccine

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Latest News